EP2531172 - PHARMACEUTICAL COMPOSITION WITH ANTI-OBESITY ACTIVITY COMPRISING A PREMIXTURE OF PURE ORLISTAT AND PREPARATION PROCESS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 18.08.2017 Database last updated on 09.09.2024 | Most recent event Tooltip | 15.11.2019 | Lapse of the patent in a contracting state New state(s): MK | published on 18.12.2019 [2019/51] | Applicant(s) | For all designated states Laboratorios Bagó S.A. Bernardo de Irigoyen 248 1072 Buenos Aires / AR | For all designated states Eastbrand Holding GmbH Börseplatz 4 1010 Wien / AT | [2016/41] |
Former [2012/50] | For all designated states Laboratorios Bagó S.A. Bernardo de Irigoyen 248 C1072AAF Buenos Aires / AR | ||
For all designated states Eastbrand Holding GmbH Börseplatz 4 1010 Wien / AT | Inventor(s) | 01 /
LOS, Mario, Atilio Bernardo de Irigoyen 248 1072 Buenos Aires / AR | [2012/50] | Representative(s) | Curell Suñol S.L.P. Muntaner 240, 4º 2ª 08021 Barcelona / ES | [N/P] |
Former [2013/32] | Curell Suñol S.L.P. Via Augusta 21 08006 Barcelona / ES | ||
Former [2012/50] | Curell Suñol, Jorge Curell Suñol S.L.P. Passeig de Gràcia 65 bis ES-08008 Barcelona / ES | Application number, filing date | 10709955.8 | 01.02.2010 | [2016/41] | WO2010EP00579 | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011091816 | Date: | 04.08.2011 | Language: | EN | [2011/31] | Type: | A1 Application with search report | No.: | EP2531172 | Date: | 12.12.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 04.08.2011 takes the place of the publication of the European patent application. | [2012/50] | Type: | B1 Patent specification | No.: | EP2531172 | Date: | 12.10.2016 | Language: | EN | [2016/41] | Search report(s) | International search report - published on: | EP | 04.08.2011 | Classification | IPC: | A61K9/00, A61K9/14, A61K9/16, A61K31/365, A61K9/20 | [2012/50] | CPC: |
A61K9/145 (EP,US);
A61K31/365 (EP,US);
A61K9/0095 (EP,US);
A61K9/2018 (EP,US);
A61K9/2054 (EP,US);
A61K9/282 (EP,US);
A61K9/286 (EP,US);
A61P3/00 (EP);
A61P3/04 (EP);
A61K9/5084 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/50] | Extension states | AL | Not yet paid | BA | Not yet paid | RS | Not yet paid | Title | German: | PHARMAZEUTISCHE ZUSAMMENSETZUNG GEGEN FETTLEIBIGKEIT MIT EINER VORMISCHUNG AUS REINEM ORLISTAT UND HERSTELLUNGSVERFAHREN | [2012/50] | English: | PHARMACEUTICAL COMPOSITION WITH ANTI-OBESITY ACTIVITY COMPRISING A PREMIXTURE OF PURE ORLISTAT AND PREPARATION PROCESS | [2012/50] | French: | COMPOSITION PHARMACEUTIQUE AYANT UNE ACTIVITÉ ANTI-OBÉSITÉ ET COMPRENANT UN PRÉ-MÉLANGE D'ORLISTAT PUR ET PROCÉDÉ DE PRÉPARATION DE CELLE-CI | [2012/50] | Entry into regional phase | 16.07.2012 | National basic fee paid | 16.07.2012 | Designation fee(s) paid | 16.07.2012 | Examination fee paid | Examination procedure | 16.07.2012 | Examination requested [2012/50] | 27.03.2013 | Amendment by applicant (claims and/or description) | 20.06.2016 | Communication of intention to grant the patent | 31.08.2016 | Fee for grant paid | 31.08.2016 | Fee for publishing/printing paid | 31.08.2016 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 20.06.2016 | Opposition(s) | 13.07.2017 | No opposition filed within time limit [2017/38] | Fees paid | Renewal fee | 17.07.2012 | Renewal fee patent year 03 | 10.12.2012 | Renewal fee patent year 04 | 04.12.2013 | Renewal fee patent year 05 | 07.01.2015 | Renewal fee patent year 06 | 29.12.2015 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 01.02.2010 | CY | 12.10.2016 | CZ | 12.10.2016 | DK | 12.10.2016 | EE | 12.10.2016 | FI | 12.10.2016 | HR | 12.10.2016 | LT | 12.10.2016 | LV | 12.10.2016 | MC | 12.10.2016 | MK | 12.10.2016 | NL | 12.10.2016 | RO | 12.10.2016 | SE | 12.10.2016 | SI | 12.10.2016 | SK | 12.10.2016 | SM | 12.10.2016 | BG | 12.01.2017 | NO | 12.01.2017 | LU | 01.02.2017 | MT | 01.02.2017 | IS | 12.02.2017 | PT | 13.02.2017 | [2019/51] |
Former [2019/46] | HU | 01.02.2010 | |
CY | 12.10.2016 | ||
CZ | 12.10.2016 | ||
DK | 12.10.2016 | ||
EE | 12.10.2016 | ||
FI | 12.10.2016 | ||
HR | 12.10.2016 | ||
LT | 12.10.2016 | ||
LV | 12.10.2016 | ||
MC | 12.10.2016 | ||
NL | 12.10.2016 | ||
RO | 12.10.2016 | ||
SE | 12.10.2016 | ||
SI | 12.10.2016 | ||
SK | 12.10.2016 | ||
SM | 12.10.2016 | ||
BG | 12.01.2017 | ||
NO | 12.01.2017 | ||
LU | 01.02.2017 | ||
MT | 01.02.2017 | ||
IS | 12.02.2017 | ||
PT | 13.02.2017 | ||
Former [2019/31] | HU | 01.02.2010 | |
CZ | 12.10.2016 | ||
DK | 12.10.2016 | ||
EE | 12.10.2016 | ||
FI | 12.10.2016 | ||
HR | 12.10.2016 | ||
LT | 12.10.2016 | ||
LV | 12.10.2016 | ||
MC | 12.10.2016 | ||
NL | 12.10.2016 | ||
RO | 12.10.2016 | ||
SE | 12.10.2016 | ||
SI | 12.10.2016 | ||
SK | 12.10.2016 | ||
SM | 12.10.2016 | ||
BG | 12.01.2017 | ||
NO | 12.01.2017 | ||
LU | 01.02.2017 | ||
MT | 01.02.2017 | ||
IS | 12.02.2017 | ||
PT | 13.02.2017 | ||
Former [2018/43] | CZ | 12.10.2016 | |
DK | 12.10.2016 | ||
EE | 12.10.2016 | ||
FI | 12.10.2016 | ||
HR | 12.10.2016 | ||
LT | 12.10.2016 | ||
LV | 12.10.2016 | ||
MC | 12.10.2016 | ||
NL | 12.10.2016 | ||
RO | 12.10.2016 | ||
SE | 12.10.2016 | ||
SI | 12.10.2016 | ||
SK | 12.10.2016 | ||
SM | 12.10.2016 | ||
BG | 12.01.2017 | ||
NO | 12.01.2017 | ||
LU | 01.02.2017 | ||
MT | 01.02.2017 | ||
IS | 12.02.2017 | ||
PT | 13.02.2017 | ||
Former [2018/04] | CZ | 12.10.2016 | |
DK | 12.10.2016 | ||
EE | 12.10.2016 | ||
FI | 12.10.2016 | ||
HR | 12.10.2016 | ||
LT | 12.10.2016 | ||
LV | 12.10.2016 | ||
MC | 12.10.2016 | ||
NL | 12.10.2016 | ||
RO | 12.10.2016 | ||
SE | 12.10.2016 | ||
SI | 12.10.2016 | ||
SK | 12.10.2016 | ||
SM | 12.10.2016 | ||
BG | 12.01.2017 | ||
NO | 12.01.2017 | ||
LU | 01.02.2017 | ||
IS | 12.02.2017 | ||
PT | 13.02.2017 | ||
Former [2017/52] | CZ | 12.10.2016 | |
DK | 12.10.2016 | ||
EE | 12.10.2016 | ||
FI | 12.10.2016 | ||
HR | 12.10.2016 | ||
LT | 12.10.2016 | ||
LV | 12.10.2016 | ||
MC | 12.10.2016 | ||
NL | 12.10.2016 | ||
RO | 12.10.2016 | ||
SE | 12.10.2016 | ||
SI | 12.10.2016 | ||
SK | 12.10.2016 | ||
SM | 12.10.2016 | ||
BG | 12.01.2017 | ||
NO | 12.01.2017 | ||
IS | 12.02.2017 | ||
PT | 13.02.2017 | ||
Former [2017/42] | CZ | 12.10.2016 | |
DK | 12.10.2016 | ||
EE | 12.10.2016 | ||
FI | 12.10.2016 | ||
HR | 12.10.2016 | ||
LT | 12.10.2016 | ||
LV | 12.10.2016 | ||
MC | 12.10.2016 | ||
NL | 12.10.2016 | ||
RO | 12.10.2016 | ||
SE | 12.10.2016 | ||
SK | 12.10.2016 | ||
SM | 12.10.2016 | ||
BG | 12.01.2017 | ||
NO | 12.01.2017 | ||
IS | 12.02.2017 | ||
PT | 13.02.2017 | ||
Former [2017/38] | CZ | 12.10.2016 | |
DK | 12.10.2016 | ||
EE | 12.10.2016 | ||
FI | 12.10.2016 | ||
HR | 12.10.2016 | ||
LT | 12.10.2016 | ||
LV | 12.10.2016 | ||
NL | 12.10.2016 | ||
RO | 12.10.2016 | ||
SE | 12.10.2016 | ||
SK | 12.10.2016 | ||
SM | 12.10.2016 | ||
BG | 12.01.2017 | ||
NO | 12.01.2017 | ||
IS | 12.02.2017 | ||
PT | 13.02.2017 | ||
Former [2017/35] | CZ | 12.10.2016 | |
DK | 12.10.2016 | ||
EE | 12.10.2016 | ||
FI | 12.10.2016 | ||
HR | 12.10.2016 | ||
LT | 12.10.2016 | ||
LV | 12.10.2016 | ||
NL | 12.10.2016 | ||
RO | 12.10.2016 | ||
SE | 12.10.2016 | ||
NO | 12.01.2017 | ||
IS | 12.02.2017 | ||
PT | 13.02.2017 | ||
Former [2017/34] | CZ | 12.10.2016 | |
DK | 12.10.2016 | ||
FI | 12.10.2016 | ||
HR | 12.10.2016 | ||
LT | 12.10.2016 | ||
LV | 12.10.2016 | ||
NL | 12.10.2016 | ||
SE | 12.10.2016 | ||
NO | 12.01.2017 | ||
IS | 12.02.2017 | ||
PT | 13.02.2017 | ||
Former [2017/33] | DK | 12.10.2016 | |
FI | 12.10.2016 | ||
HR | 12.10.2016 | ||
LT | 12.10.2016 | ||
LV | 12.10.2016 | ||
NL | 12.10.2016 | ||
SE | 12.10.2016 | ||
NO | 12.01.2017 | ||
IS | 12.02.2017 | ||
PT | 13.02.2017 | ||
Former [2017/26] | FI | 12.10.2016 | |
HR | 12.10.2016 | ||
LT | 12.10.2016 | ||
LV | 12.10.2016 | ||
NL | 12.10.2016 | ||
SE | 12.10.2016 | ||
NO | 12.01.2017 | ||
IS | 12.02.2017 | ||
PT | 13.02.2017 | ||
Former [2017/12] | LV | 12.10.2016 | Cited in | International search | [ID]US6004996 (SHAH NAVNIT HARGOVINDAS [US], et al) [ID] 1-25 * example -; claim - * * tables 3-5 ** claim - *; | [X]US2006246141 (LIVERSIDGE GARY G [US], et al) [X] 1-6,8,12-25 * paragraphs [0077] , [ 102] - [0111] *; | [X]WO2009044380 (RANBAXY LAB LTD [IN], et al) [X] 1-25 * page 3, lines 8-18 * * page 4, line 18 - page 5, line 2 * * examples 1-5 * * claim - *; | [I]WO2009116880 (ZAKLADY FARM POLPHARMA SA [PL], et al) [I] 1-25 * page 2, lines 13-19 * * page 4, line 7 - page 5, line 2 * * examples 1-6 * * claim - * | by applicant | US3923976 | EP0129748 | US4598089 | US6004996 | AR010704 | AR025609 | US6703369 | - STALDER HENRI; SCHNEIDER PIERRE; GOTTFRIED OESTERHELT, "Tetrahydrolipstatin: Thermal and Hydrolytic Degradation", HELVETICA CHIMICA ACTA, (1990), vol. 73, pages 1022 - 1035 |